koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastiska medel - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
cibinqo
pfizer europe ma eeig - abrocitinib - dermatit, atopisk - andra dermatologiska preparat - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiska medel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib medical valley 37,5 mg kapsel, hård
medical valley invest ab - sunitinibmalat - kapsel, hård - 37,5 mg - sunitinibmalat 50,1 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne; tartrazin hjälpämne; para-orange hjälpämne
sunitinib avansor 50 mg kapsel, hård
avansor pharma oy - sunitinibmalat - kapsel, hård - 50 mg - sunitinibmalat 66,83 mg aktiv substans
sunitinib avansor 12,5 mg kapsel, hård
avansor pharma oy - sunitinibmalat - kapsel, hård - 12,5 mg - sunitinibmalat 16,71 mg aktiv substans
sunitinib avansor 25 mg kapsel, hård
avansor pharma oy - sunitinibmalat - kapsel, hård - 25 mg - sunitinibmalat 33,41 mg aktiv substans
sunitinib newbury 50 mg kapsel, hård
newbury pharmaceuticals ab - sunitinibmalat - kapsel, hård - 50 mg - sunitinibmalat 66,8 mg aktiv substans; propylenglykol hjälpämne; mannitol hjälpämne
sunitinib newbury 37,5 mg kapsel, hård
newbury pharmaceuticals ab - sunitinibmalat - kapsel, hård - 37,5 mg - sunitinibmalat 50,1 mg aktiv substans; tartrazin hjälpämne; propylenglykol hjälpämne; mannitol hjälpämne; para-orange hjälpämne
sunitinib sandoz 37,5 mg kapsel, hård
sandoz a/s - sunitinib - kapsel, hård - 37,5 mg - sunitinib 37,5 mg aktiv substans; mannitol hjälpämne; propylenglykol hjälpämne